Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Elife. 2024 Sep 12;13:RP98181. doi: 10.7554/eLife.98181.
Reactive astrocytes play critical roles in the occurrence of various neurological diseases such as multiple sclerosis. Activation of astrocytes is often accompanied by a glycolysis-dominant metabolic switch. However, the role and molecular mechanism of metabolic reprogramming in activation of astrocytes have not been clarified. Here, we found that PKM2, a rate-limiting enzyme of glycolysis, displayed nuclear translocation in astrocytes of EAE (experimental autoimmune encephalomyelitis) mice, an animal model of multiple sclerosis. Prevention of PKM2 nuclear import by DASA-58 significantly reduced the activation of mice primary astrocytes, which was observed by decreased proliferation, glycolysis and secretion of inflammatory cytokines. Most importantly, we identified the ubiquitination-mediated regulation of PKM2 nuclear import by ubiquitin ligase TRIM21. TRIM21 interacted with PKM2, promoted its nuclear translocation and stimulated its nuclear activity to phosphorylate STAT3, NF-κB and interact with c-myc. Further single-cell RNA sequencing and immunofluorescence staining demonstrated that TRIM21 expression was upregulated in astrocytes of EAE. TRIM21 overexpressing in mice primary astrocytes enhanced PKM2-dependent glycolysis and proliferation, which could be reversed by DASA-58. Moreover, intracerebroventricular injection of a lentiviral vector to knockdown TRIM21 in astrocytes or intraperitoneal injection of TEPP-46, which inhibit the nuclear translocation of PKM2, effectively decreased disease severity, CNS inflammation and demyelination in EAE. Collectively, our study provides novel insights into the pathological function of nuclear glycolytic enzyme PKM2 and ubiquitination-mediated regulatory mechanism that are involved in astrocyte activation. Targeting this axis may be a potential therapeutic strategy for the treatment of astrocyte-involved neurological disease.
反应性星形胶质细胞在多发性硬化等多种神经疾病的发生中起着关键作用。星形胶质细胞的激活通常伴随着糖酵解主导的代谢转换。然而,代谢重编程在星形胶质细胞激活中的作用和分子机制尚不清楚。在这里,我们发现糖酵解的限速酶 PKM2 在多发性硬化症的动物模型 EAE(实验性自身免疫性脑脊髓炎)小鼠的星形胶质细胞中发生核转位。通过 DASA-58 阻止 PKM2 核内输入显著减少了小鼠原代星形胶质细胞的激活,这表现为增殖、糖酵解和炎症细胞因子分泌减少。最重要的是,我们确定了泛素连接酶 TRIM21 通过泛素化介导的 PKM2 核输入调节。TRIM21 与 PKM2 相互作用,促进其核转位,并刺激其核活性磷酸化 STAT3、NF-κB 并与 c-myc 相互作用。进一步的单细胞 RNA 测序和免疫荧光染色表明,TRIM21 在 EAE 星形胶质细胞中表达上调。在小鼠原代星形胶质细胞中过表达 TRIM21 增强了依赖于 PKM2 的糖酵解和增殖,这可以被 DASA-58 逆转。此外,向星形胶质细胞中脑室内注射慢病毒载体以敲低 TRIM21 或腹腔内注射抑制 PKM2 核转位的 TEPP-46,可有效减轻 EAE 的疾病严重程度、中枢神经系统炎症和脱髓鞘。总之,我们的研究为核糖酵解酶 PKM2 的病理功能和涉及星形胶质细胞激活的泛素化介导的调节机制提供了新的见解。靶向该轴可能是治疗星形胶质细胞参与的神经疾病的潜在治疗策略。